Showing results (91-100 of 162) with videos related to

Sort By:
Pageof 17
Blood|August 9, 2003
Molecular histogenesis of posttransplantation lymphoproliferative disordersDaniela Capello, Michaela Cerri, Giuliana Muti, et al.
European Radiology|August 21, 2020
Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?Marco Lucioni, Chiara Rossi, Pascal Lomoro, et al.
The American Journal of Gastroenterology|December 5, 2023
Long-Term Natural History of Autoimmune Gastritis: Results From a Prospective Monocentric SeriesEmanuela Miceli, Marco Vincenzo Lenti, Antonella Gentile, et al.
Hematological Oncology|August 31, 2023
Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panelPietro Quaglino, Nicola Pimpinelli, Pier Luigi Zinzani, et al.
Blood|January 29, 2013
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasmsMarzia Varettoni, Luca Arcaini, Silvia Zibellini, et al.
Hematological Oncology|April 10, 2016
Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphomaManuel Gotti, Marta Nicola, Marco Lucioni, et al.
British Journal of Haematology|March 17, 2026
Mediastinal grey zone lymphomas: Results of the expert pathological review analysis of a case series enrolled in the multicentre BIOGZL-2020 study in ItalyElena Sabattini, Stefano Ascani, Sabino Ciavarella, et al.
Histopathology|June 22, 2012
IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomasBrunangelo Falini, Claudio Agostinelli, Barbara Bigerna, et al.
Clinical Science (London, England : 1979)|May 19, 2020
Deregulation of miRNAs-cMYC circuits is a key event in refractory celiac disease type-2 lymphomagenesisValentina Vaira, Gabriella Gaudioso, Maria Antonella Laginestra, et al.
British Journal of Haematology|July 6, 2019
A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disordersMarzia Varettoni, Silvia Zibellini, Emanuela Boveri, et al.
Pageof 17